Cargando…

Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma

BACKGROUND: Acquired drug resistance is a constraining factor in clinical treatment of glioblastoma (GBM). However, the mechanisms of chemoresponsive tumors acquire therapeutic resistance remain poorly understood. Here, we aim to investigate whether temozolomide (TMZ) resistance of chemoresponsive G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhuoran, Yin, Jianxing, Lu, Chenfei, Wei, Yutian, Zeng, Ailiang, You, Yongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469146/ https://www.ncbi.nlm.nih.gov/pubmed/30992025 http://dx.doi.org/10.1186/s13046-019-1139-6

Ejemplares similares

Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma
por: Yin, Jianxing, et al.
Publicado: (2019)

Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p
por: Yin, Jianxing, et al.
Publicado: (2021)

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma
por: Lu, Chenfei, et al.
Publicado: (2020)

EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1–2 signaling
por: Wei, Yutian, et al.
Publicado: (2020)

Hypoxanthine phosphoribosyl transferase 1 metabolizes temozolomide to activate AMPK for driving chemoresistance of glioblastomas
por: Yin, Jianxing, et al.
Publicado: (2023)

MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype
por: Yan, Wei, et al.
Publicado: (2015)

Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis
por: Yu, Cheng, et al.
Publicado: (2020)

Tumour exosomes from cells harbouring PTPRZ1–MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma
por: Zeng, A-L, et al.
Publicado: (2017)

Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide
por: Sun, Stella, et al.
Publicado: (2012)

Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma
por: Nie, Er, et al.
Publicado: (2018)

Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma
por: Lu, Can, et al.
Publicado: (2022)

miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma
por: Zeng, Ailiang, et al.
Publicado: (2018)

MiR-181b suppress glioblastoma multiforme growth through inhibition of SP1-mediated glucose metabolism
por: Yin, JianXing, et al.
Publicado: (2020)

Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA‐101 in glioblastoma
por: Cai, Tao, et al.
Publicado: (2018)

Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
por: Wang, Ke, et al.
Publicado: (2017)

High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer
por: Lv, Junjie, et al.
Publicado: (2016)

Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells
por: Cheng, Quan, et al.
Publicado: (2017)

Downregulated ferroptosis‐related gene SQLE facilitates temozolomide chemoresistance, and invasion and affects immune regulation in glioblastoma
por: Yao, Lei, et al.
Publicado: (2022)

Potential roles of exosome non-coding RNAs in cancer chemoresistance
por: Wang, Yueyue, et al.
Publicado: (2021)

MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells()
por: Li, Ping, et al.
Publicado: (2010)

Exosomal transfer of miR-25-3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7
por: Wang, Jianxin, et al.
Publicado: (2021)

Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells
por: Zeng, Huijun, et al.
Publicado: (2017)

Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma
por: Wang, Jia, et al.
Publicado: (2019)

MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53
por: Zhou, Xu, et al.
Publicado: (2017)

STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B
por: Yuan, Shuai, et al.
Publicado: (2022)

Chemoresistance Transmission via Exosome-Transferred MMP14 in Pancreatic Cancer
por: Li, Xinyuan, et al.
Publicado: (2022)

AKT2-knockdown suppressed viability with enhanced apoptosis, and attenuated chemoresistance to temozolomide of human glioblastoma cells in vitro and in vivo
por: Cui, Yong, et al.
Publicado: (2015)

Aberrant Transcriptional Regulation of Super-enhancers by RET Finger Protein-histone Deacetylase 1 Complex in Glioblastoma: Chemoresistance to Temozolomide
por: NATSUME, Atsushi, et al.
Publicado: (2019)

BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53
por: Nie, Er, et al.
Publicado: (2016)

Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma
por: Chen, Rui, et al.
Publicado: (2019)

The impact of SBF2 on taxane-induced peripheral neuropathy
por: Cunningham, Geneva M., et al.
Publicado: (2022)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells
por: Hellmold, Dana, et al.
Publicado: (2023)

Exosome-mediated breast cancer chemoresistance via miR-155 transfer
por: Santos, Juliana Carvalho, et al.
Publicado: (2018)

Genome-wide identification of epithelial-mesenchymal transition-associated microRNAs reveals novel targets for glioblastoma therapy
por: Zhang, Yong, et al.
Publicado: (2018)

Evaluation of Temozolomide Treatment for Glioblastoma Using Amide Proton Transfer Imaging and Diffusion MRI
por: Onishi, Ryutarou, et al.
Publicado: (2022)

Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer
por: Deng, Jinhai, et al.
Publicado: (2023)

Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide
por: Quan, Rencui, et al.
Publicado: (2020)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Strategies of temozolomide in future glioblastoma treatment
por: Lee, Chooi Yeng
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qjpfg2kom9j91qpuf3b87bpga1